MeSH D012131 - respiratory insufficiency
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012120:Respiration disorders
D000142:Respiratory acidosis
0 Companies
0 Drugs
Success rate
D000402:Airway obstruction
D006102:Laryngeal granuloma
0 Companies
0 Drugs
Success rate
D007040:Hypoventilation
D012133:Respiratory paralysis
0 Companies
0 Drugs
Success rate
D018467:Intrinsic positive-pressure respiration
0 Companies
0 Drugs
Success rate
D018804:Hantavirus pulmonary syndrome
0 Companies
0 Drugs
Success rate
D057768:Resolved brief unexplained event
0 Companies
0 Drugs
Success rate
D000097742:Patient-ventilator asynchrony
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Linde Healthcare | Nitric oxide | INOmax | 2001-08-01 |
Clinical Trials
Historical Success Rate
Phase 1
50%11/22
Phase 2
43%26/60
Phase 3
21%11/52
Approved: 1Overall Success rate: 5%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use